Genome Institute Plans Public Meeting on Future Funding
Published Date: 7/13/2026
Notice
Summary
The National Human Genome Research Institute is holding a public meeting on September 28-29, 2026, to share updates and review grant applications. Scientists, researchers, and anyone interested in human genetics can join in person or online. This meeting helps decide which projects get funding, so it impacts future research and innovation in genetics.
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
Public may attend in person or online
You can attend the National Advisory Council for Human Genome Research meeting in person on September 28, 2026 (10:30 a.m. to 5:00 p.m.) at 6700 Rockledge Drive, Suite 3100, Rockledge, MD, or watch it live via the NIH Videocast at https://videocast.nih.gov/. The meeting includes an open session on September 28, 2026 and is limited to space available for in-person attendance.
Grant review session closed to public
The council will hold a closed session on September 29, 2026 from 10:30 a.m. to 5:00 p.m. to review and evaluate grant applications. The closure is under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, commercial property, and personal information of applicants.
Anyone may file written comments
Any interested person may submit written comments to the committee by sending a statement to the Contact Person listed in the notice. The statement should include your name, address, telephone number, and, if applicable, your business or professional affiliation.
Reasonable accommodations available on request
If you plan to attend and need special assistance (for example, sign language interpretation or other reasonable accommodations), you should notify the Contact Person listed in the notice in advance of the meeting. This applies to the in-person meeting at 6700 Rockledge Drive and to arrangements for participation.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-14003 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important research grant applications. These meetings keep sensitive info private, protecting ideas and personal details. Scientists applying for grants and the research community will feel the impact as funding decisions get made on time.
2026-13802 — Government Owned Invention Available for License: Generating Conditional and Reverse Conditional Loss-of-Function Alleles in Mouse Casq2
The National Institutes of Health is offering special mouse strains that help study a rare heart rhythm disorder called CPVT. These mice let scientists explore how a key heart gene works and test new gene therapies. Researchers interested in this tool can access it now—no patents, just pure science ready to speed up discoveries!
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
Previous / Next Documents
Previous: 2026-14000 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early August 2026 to review and evaluate important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants in areas like HIV, heart disease, and brain disorders should note these dates as they impact funding decisions.
Next: 2026-14002 — Center For Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on July 27, 2026, to review important grant applications about drug and biologic delivery. This meeting is private to protect secret ideas and personal info, affecting researchers waiting on funding decisions. No new money or timing changes are announced, but this review is a key step in moving science forward.